Testing a sleep drug for suicide risk in veterans with depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a medication called suvorexant (used for sleep) can help lower suicide risk in veterans who have major depression and have attempted suicide before. The study aims to see if blocking a brain chemical called orexin reduces suicidal thoughts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran
- You are between 18 and 70 years old
- You have major depressive disorder (diagnosed by a doctor)
- You have tried to kill yourself in the past and currently have thoughts of suicide
- You are not taking certain medications (ask the study team for details)
- You do not have active substance abuse, bipolar disorder, OCD, or a psychotic disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.
This research study tests different medication approaches for people with major depression who are having thoughts of suicide. The goal is to understand which treatments work best and why, so doctors can help patients more effectively.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This study tests if the sleep medication suvorexant can improve both sleep and PTSD symptoms in veterans. If you have PTSD and insomnia, and you are a veteran, this might be a treatment option for you.
This study tests if a medication that blocks a brain chemical called orexin can help people with PTSD sleep better and reduce fear. You must have chronic PTSD, trouble sleeping, and be a U.S. military veteran.
This trial tests suvorexant, a sleep medicine, to help improve sleep disturbance in people with PTSD. It’s designed for adults who have had PTSD symptoms for at least a few months and also have insomnia.
Hear when a new Suicide Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.